by John Conrad | Dec 4, 2019 | Community News
Veteran entrepreneurs and cofounders of Actuate Therapeutics, Inc., Daniel Schmitt and Andrew Mazar, PhD, are taking no chances with their lead clinical candidate 9-ING-41, a promising new treatment for advanced and drug-resistant cancers and select inflammatory...
by John Conrad | Nov 18, 2019 | Community News
Endotronix, a digital health and medical technology company dedicated to advancing the treatment of chronic heart failure (HF), presented positive first-in-human data of the Cordella™ Pulmonary Artery (PA) Pressure Sensor System (Cordella Sensor). Data was presented...
by John Conrad | Nov 15, 2019 | Community News
Actuate Therapeutics, Inc. has raised an additional $6.5M in a Series B-3 financing round led by Bios Partners with Kairos Ventures, DEFTA Partners, and other existing investors participating. This Series B-3 brings total funding for Actuate’s Series B round to over...
by John Conrad | Nov 15, 2019 | Community News
Exicure to Receive $25 Million Upfront Payment and Up to $725 Million in potential Milestones CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exicure, Inc., (NASDAQ:XCUR) a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic...
by John Conrad | Nov 15, 2019 | Community News
Applications are now being accepted for MedTech Innovator 2020. This is a unique opportunity for start-ups and emerging growth medical technology companies to gain access to industry stakeholders such as Baxter, BTG, HOYA, Maxim Ventures, Johnson & Johnson,...
by John Conrad | Nov 11, 2019 | Community News
Cyclopure based out of the Illinois Science + Technology Park in Skokie, Illinois was named in C&EN’s annual list of startups to watch. CycloPure is a materials science company and a leader in water purification technologies. The company’s line of DEXSORB...
